249 CTLA4 Ig and Cyclophosphamide Can Inhibit an Antibody Response to Human Factor × in Balb/C Mice after Retroviral Vector Mediated Gene Therapy Molecular Therapy Vol 5, No 5, May 2002, Part 2 of 2[.]
Trang 1Molecular Therapy Vol 5, No 5, May 2002, Part 2 of 2 Parts Copyright © The American Society of Gene Therapy
S82
=" "
=" "
247 Preclinical T
247 Preclinical Trials of a Helper-Dependent rials of a Helper-Dependent
Adenoviral V
Adenoviral Vector for the T ector for the T ector for the Treatment of Murine and reatment of Murine and
Canine Models of Hemophilia A
Brian D Brown, 1 Chang Xin Shi, 2 Fiona Grant, 1 Shawn Tinlin, 1
Alexis McKinven, 1 Sandra Webster, 1 Frank L Graham, 2 David P.
Lillicrap 1
1 Department of Pathology, Queens University, Kingston, Ontario,
Canada; 2 Department of Biology, McMaster University, Hamilton,
Ontario, Canada.
&389 89 &389 88
88 88
8, %
8389 8,
248 Gene Therapy for Hemophilia A Using Lentiviral V
Vectors ectors
Neeltje A Kootstra, 1 Ryusuke Matsumura, 1 Inder M Verma 1
1 Lab of Genetics, The Salk Institute, La Jolla, CA, United States.
249 CTLA4-Ig and Cyclophosphamide Can Inhibit an Antibody Response to Human Factor X in Balb/C Mice after Retroviral V
after Retroviral Vector-Mediated Gene Therapy ector-Mediated Gene Therapy
Jun Zhang, Frances Wong, Cuihua Gao, Lingfei Xu, Jason Wong, Katherine P Ponder.
1 Department of Internal Medicine and Biochemistry and Molecular Biophysics, Washington University School of Medicine, St Louis, MO, United States.
Trang 2Molecular Therapy Vol 5, No 5, May 2002, Part 2 of 2 Parts
=" "
5
250 High Level Expression of Canine Factor IX in
Hemophilia B Dogs after Readminstration of
Hemophilia B Dogs after Readminstration of AA AA AAV2/5 V2/5
V
Vectors ectors
Lili Wang, 1 Timothy C Nichols, 2 Marjorie S Read, 2 Dwight A.
Bellinger, 2 Inder M Verma, 3 James M Wilson 1
1 Institute for Human Gene Therapy, University of Pennsylvania,
Philadelphia, PA, United States; 2 Department of Pathology and
Laboratory Medicine, University of North Carolina, Chapel Hill,
NC, United States; 3 Laboratory of Genetics, The Salk Institute, La
Jolla, CA, United States.
251 Creation and Characterization of High T
251 Creation and Characterization of High Titer iter iter AA AA AAV V V -Factor IX Producing Clones for Clinical Scale Production
Debbie Farson, 1 Lucy Tao, 1 Jun Liu, 1 Thomas Harding, 1 Brian Donahue 1
1 Research, Cell Genesys, Inc., Foster City, CA, United States.
6
6
88
252 Epstein-Barr V
252 Epstein-Barr Virus V irus V irus Vectors Provide Prolonged ectors Provide Prolonged Vigorous Factor IX Expression in Mice
Christopher R Sclimenti, 1 Andrew Nevaiser, 1 Edward Baba, 1
Leonard Meuse, 2 Mark A Kay, 2 Michele P Calos 1
1 Department of Genetics, School of Medicine, Stanford University, Stanford, CA, United States; 2 Department of Pediatrics, School of Medicine, Stanford University, Stanford, CA, United States.